Aardvark Therapeutics (AARD) Stock Chart & Stock Price History $11.29 -0.48 (-4.08%) As of 06/11/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Aardvark Therapeutics Stock Price Performance The Aardvark Therapeutics (AARD) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has increased 2.92%, reflecting recent market activity. As of the latest close, Aardvark Therapeutics traded at $11.29 with a market cap of $244.95 million and volume of 13,721 shares. Receive AARD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aardvark Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.40%1 Month Performance+2.92%3 Month Performance+11.34% AARD Stock Chart for Thursday, June, 12, 2025 AARD Chart by TradingView Aardvark Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/11/2025$11.77$11.29-4.08%$11.93$10.9613,721 shs$244.95 million06/10/2025$11.68$11.77+0.77%$12.05$11.5612,561 shs$255.36 million06/09/2025$11.81$11.68-1.10%$12.19$11.4525,480 shs$253.41 million06/06/2025$11.95$11.81-1.17%$12.22$11.8029,676 shs$256.23 million06/05/2025$11.70$11.95+2.14%$12.05$11.5833,708 shs$259.27 million06/04/2025$11.66$11.70+0.34%$12.14$10.7632,573 shs$253.84 million06/03/2025$11.13$11.66+4.76%$12.02$11.2136,701 shs$252.98 million06/02/2025$10.52$11.13+5.80%$11.50$10.7226,604 shs$241.48 million05/30/2025$10.30$10.52+2.14%$10.67$10.3818,454 shs$228.24 million05/29/2025$10.21$10.30+0.88%$10.72$10.2312,504 shs$223.47 million Get the Latest News and Ratings for AARD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aardvark Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/28/2025$9.82$10.21+3.97%$10.41$9.9913,877 shs$221.52 million05/27/2025$10.50$9.82-6.48%$10.93$9.7632,577 shs$213.06 million05/26/2025$10.50$10.50$10.81$9.6722,053 shs$227.81 million05/23/2025$10.01$10.50+4.90%$10.81$9.6722,053 shs$227.81 million05/22/2025$11.12$10.01-9.98%$11.38$9.9026,583 shs$217.18 million05/21/2025$11.00$11.12+1.09%$11.50$10.4023,747 shs$241.26 million05/20/2025$10.43$11.00+5.47%$11.00$10.4219,980 shs$238.66 million05/19/2025$9.89$10.43+5.46%$10.50$9.7044,444 shs$226.29 million05/16/2025$9.09$9.89+8.80%$10.01$8.7519,150 shs$214.57 million05/15/2025$8.74$9.09+4.00%$10.55$8.7443,653 shs$197.22 million05/14/2025$10.14$8.74-13.81%$10.26$8.50146,968 shs$189.62 million05/13/2025$10.97$10.14-7.57%$11.38$10.0052,328 shs$220.00 million05/12/2025$10.42$10.97+5.28%$11.03$10.1519,641 shs$238.01 million Related Companies AVDL Stock Price Chart GYRE Stock Price Chart PHVS Stock Price Chart ELVN Stock Price Chart NAGE Stock Price Chart OCS Stock Price Chart LENZ Stock Price Chart CRMD Stock Price Chart QURE Stock Price Chart CMRX Stock Price Chart Receive AARD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aardvark Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AARD) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aardvark Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aardvark Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
